The World’s Premier Forum to Advance Differentiated ADCs to Redefine Early-Line Oncology Patient Outcomes
In the age of Topo1 clinical saturation and threat of patient resistance mechanisms, the need for differentiation is not a new challenge for the ADC community. With biopharma investing heavily into de-risk future ADC development, non-traditional ADCs continue to take the spotlight to secure an effective future landscape of therapies to patients in need.
Across bispecific and dual payload ADCs, DACs, AOCs, ISACs and beyond, the 10-year CAGR of non-traditional ADC unique patent families published is 23% vs 11% for traditional ADCs. Between January 2025 to February 2026, the number of non-traditional ADC drugs almost doubled, with 99% growth and 575 non-traditional ADCs identified*.
The 17th World ADC San Diego holds the standard to be at the forefront of bioconjugate development, spotlighting all the avenues of ADC innovation under one roof. If you want to stay competitive in the field, you cannot miss World ADC San Diego to de-risk future ADC development and push ADCs to earlier-line oncology treatments.
*Data according to Beacon – correct as of April 2026.
More Than a Meeting: Celebrate the World ADC Networking Experience
As over 1300 of the best and brightest in ADC development unite at the definitive industry orientation point for all things ADC, don’t miss out on the structured networking and informal socializing activities beyond the scientific program, including:
Brand New Companies Making Their World ADC Debut
Included within the 170+ industry-leading speaker faculty, World ADC San Diego is committed to spotlight novel perspectives on ADC development, with brand-new presenting companies:
Explore the Full Event Guide
- 1,300+ Industry Attendees
- 170+ World-Class Speaker Faculty
- 400+ Attending Companies
- 7 Tracks of End-to-End ADC Content
- 17 Hours of Structured & Informal Networking
- The World’s Largest & Definitive ADC Forum
Agenda Highlights
Below is a snapshot of what you can expect over the four days of cutting-edge content to help you plan your time effectively.
Seminar Day - Monday, October 12
Positioned before Scientific Program Day One & Two, the Seminar Day is your perfect opportunity to delve into key ADC innovation, bottlenecks and advancement across areas including novel conjugates, toxicity, combinations, CQAs and clinical and commercial-stage CMC – all led by forward-thinking ADC experts:
Introduction to ADCs Day
Gain a Core Understanding of Essential ADC Discovery & Early Development
4th Novel Conjugates Day
Pushing the Boundary of Novel Bioconjugate Mechanisms & Design
2rd Pharmacology Day
Accelerating the Next Wave of Tumor-Targeting Mechanisms & Behavior
7th Toxicity Day
Predicting, Characterizing & Mitigating ADC Toxicities to Widen Therapeutic Index
10th ADCs in Combination Day
Unlocking the Power of Rationale-Driven ADC Combinations
2nd Analytical & CQA Day
Elevating Confident Characterization of Increasingly Complex Conjugates
8th CMC Day
Manufacturing Cost Efficient & Regulatory Compliant ADCs at Scale
9th ADCs in Combinations Day
Smartly select ADC combination partners to tackle patient resistance
Scientific Program Days: Tuesday, October 13 & Wednesday, October 14
Headlined with keynote plenary sessions from senior ADC industry and physician KOLS showcasing blockbuster clinical development to early-line oncology settings and differentiated ADC profiles to ensure future patient impact, the main scientific program days will deliver cutting-edge, end-end ADC case studies and development insights across seven content tracks:
- Discovery Chemistry
- Discovery Biology
- Preclinical
- Translational Medicine
- Clinical Lessons
- Process & Analytical Development
- Manufacturing & Supply Stream
Throughout both days, access structured and informal networking opportunities to make new scientific and business “linkers” with biopharma and service providers as the ADC community reunites all under one roof.
After the scientific presentations, make sure you don’t miss the popular Evening Drinks Reception on Day One and 13th World ADC Awards on Day Two.
Workshop Day: Thursday, October 15
Invigorated with new insights from the previous three days, continue the conversation with like-minded peers in a series of discussions, debates, and forward-thinking sessions to find solutions to your most pressing challenges in the ADC field.
Taking place in more intimate settings, this is the prime opportunity to voice your questions and challenge your peers in these collaborative sessions tailored for all day-to-day aspects of ADC development:
Pick one morning workshop:
- Assessing the Development & Emerging Potential of Immune-Stimulating & Immune-Suppressing ADCs in Oncology & Beyond
- Translating ADC Tolerability: Deep-Diving Into Toxicity Characterization & Preclinical Strategy to Better Predict ADC Clinical Safety Profiles
- Connecting ADC Design & Component Contribution to Clinical Safety & Efficacy: What Makes a Clinically Impactful ADC?
- Exploring the Depths & Breadth of ADC Bioanalysis to Ensure In-Depth PK/PD Analysis & Best Inform Clinical Strategy
- Deep Diving Into CMC Best Practices to Ensure Stakeholder Alliance to Optimize ADC Production & Regulatory CMC Strategy
Pick one afternoon workshop:
- Encompassing the Breadth of Conjugation Approaches to Optimize Bioconjugate Design & Performance Across Traditional, Dual Payload ADCs & Beyond
- Balancing the Pace of Preclinical Development & Confident In Vivo Analysis to Optimize ADC Speed to Clinic
- Breaking Down Trends & Strategies to Maximize ADC Clinical Impact in an Increasingly Busy Oncology Landscape
- Beyond Traditional ADCs: Breaking Down Control Strategies for Non Cytotoxic Bioconjugate Modalities
- CMC Fundamentals from Gene & Payload to IND: Exploring Typical Workplans, Best Practices, Common Pitfalls, & Tips to Manage a Complex Supply Chain
Explore the Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.